Screening a prognosis-related target gene in patients with HER-2 positive breast cancer by bioinformatics analysis

Conclusions: The present study identified RRM2 as a target gene associated with the initiation, progression and prognosis of HER-2 positive breast cancer, which may contribute to provide a new biomarker and therapeutic target.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research